Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Even modest exercise makes a big difference for liver disease patients. A large population-based study found that individuals with steatotic liver disease who engaged in any leisure-time physical activity had a 16% lower risk of all-cause mortality compared to those who were completely inactive — and the benefit held regardless of fibrosis severity. The biggest gains came from simply going from zero activity to any activity at all.
Even a little movement goes a long way for steatotic liver disease patients. A 31-year population-based study presented at the ACG Annual Scientific Meeting found that any leisure-time physical activity was associated with a 16% lower risk of all-cause mortality in adults with steatotic liver disease (SLD) — and that benefit was independent of baseline fibrosis status. Researchers analyzed data from over 4,400 adults drawn from NHANES (1988–1994), tracking outcomes through 2019.
The most striking finding? The greatest mortality reduction came when people moved from being completely sedentary to doing any physical activity at all — not necessarily hitting guideline-recommended targets. Researchers believe much of the benefit operates through cardiometabolic pathways rather than direct liver effects, since fibrosis stage didn't significantly alter the association.
By the Numbers:
Why it matters: For clinicians managing SLD patients, this reinforces physical activity as a cornerstone of care — not just for liver health, but for overall survival. The message is simple: even getting a sedentary patient to start walking could be a life-saving intervention.
